Australian Pharmacist

By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.

The significant rise in Australian asthma deaths is cause for immediate and widespread concern. Here’s what experts say needs to change.

After much media scrutiny, the federal Department of Health and Aged Care has announced a ban on compounded GLP-1RAs.

Can oxybutynin be useful for some patients who are unsuited for hormonal pharmacotherapy? Some people might describe hot flashes as an unannounced and brief...

A new wave of private prescriptions may be approaching, as the Active Ingredient Prescribing (AIP) grace period comes to an end.

Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...